187 related articles for article (PubMed ID: 8905755)
1. Prevention of cerebral vasospasm by calcitonin gene-related peptide slow-release tablet after subarachnoid hemorrhage in monkeys.
Inoue T; Shimizu H; Kaminuma T; Tajima M; Watabe K; Yoshimoto T
Neurosurgery; 1996 Nov; 39(5):984-90. PubMed ID: 8905755
[TBL] [Abstract][Full Text] [Related]
2. Development of calcitonin gene-related peptide slow-release tablet implanted in CSF space for prevention of cerebral vasospasm after experimental subarachnoid haemorrhage.
Ahmad I; Imaizumi S; Shimizu H; Kaminuma T; Ochiai N; Tajima M; Yoshimoto T
Acta Neurochir (Wien); 1996; 138(10):1230-40. PubMed ID: 8955444
[TBL] [Abstract][Full Text] [Related]
3. Effect of calcitonin gene-related peptide on delayed cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits.
Imaizumi S; Shimizu H; Ahmad I; Kaminuma T; Tajima M; Yoshimoto T
Surg Neurol; 1996 Sep; 46(3):263-70; discussion 270-1. PubMed ID: 8781597
[TBL] [Abstract][Full Text] [Related]
4. The effect of timing of clot removal on chronic vasospasm in a primate model.
Handa Y; Weir BK; Nosko M; Mosewich R; Tsuji T; Grace M
J Neurosurg; 1987 Oct; 67(4):558-64. PubMed ID: 3655894
[TBL] [Abstract][Full Text] [Related]
5. [Effect of calcitonin gene-related peptide and vasoactive intestinal polypeptide on delayed cerebral vasospasm studied after experimental subarachnoid hemorrhage in rabbits].
Shimizu H; Imaizumi S; Ishtiaq A; Kaminuma T; Tajima M; Yoshimoto T
No Shinkei Geka; 1994 Feb; 22(2):131-9. PubMed ID: 8115007
[TBL] [Abstract][Full Text] [Related]
6. Prospective, randomized, double-blind trial of BQ-123 and bosentan for prevention of vasospasm following subarachnoid hemorrhage in monkeys.
Hino A; Weir BK; Macdonald RL; Thisted RA; Kim CJ; Johns LM
J Neurosurg; 1995 Sep; 83(3):503-9. PubMed ID: 7666230
[TBL] [Abstract][Full Text] [Related]
7. Gene transfer of calcitonin gene-related peptide prevents vasoconstriction after subarachnoid hemorrhage.
Toyoda K; Faraci FM; Watanabe Y; Ueda T; Andresen JJ; Chu Y; Otake S; Heistad DD
Circ Res; 2000 Oct; 87(9):818-24. PubMed ID: 11055987
[TBL] [Abstract][Full Text] [Related]
8. Increased cerebral blood flow but no reversal or prevention of vasospasm in response to L-arginine infusion after subarachnoid hemorrhage.
Pluta RM; Afshar JK; Thompson BG; Boock RJ; Harvey-White J; Oldfield EH
J Neurosurg; 2000 Jan; 92(1):121-6. PubMed ID: 10616090
[TBL] [Abstract][Full Text] [Related]
9. Effect of cyclosporine on the development of cerebral vasospasm in a primate model.
Handa Y; Hayashi M; Takeuchi H; Kobayashi H; Kawano H; Kabuto M
Neurosurgery; 1991 Mar; 28(3):380-5; discussion 385-6. PubMed ID: 2011219
[TBL] [Abstract][Full Text] [Related]
10. Effects of subarachnoid hemorrhage on vascular responses to calcitonin gene-related peptide and its related second messengers.
Sutter B; Suzuki S; Arthur AS; Kassell NF; Lee KS
J Neurosurg; 1995 Sep; 83(3):516-21. PubMed ID: 7666231
[TBL] [Abstract][Full Text] [Related]
11. Posttreatment with adenovirus-mediated gene transfer of calcitonin gene-related peptide to reverse cerebral vasospasm in dogs.
Satoh M; Perkins E; Kimura H; Tang J; Chun Y; Heistad DD; Zhang JH
J Neurosurg; 2002 Jul; 97(1):136-42. PubMed ID: 12134904
[TBL] [Abstract][Full Text] [Related]
12. Role of ferrous iron chelator 2,2'-dipyridyl in preventing delayed vasospasm in a primate model of subarachnoid hemorrhage.
Horky LL; Pluta RM; Boock RJ; Oldfield EH
J Neurosurg; 1998 Feb; 88(2):298-303. PubMed ID: 9452239
[TBL] [Abstract][Full Text] [Related]
13. Effect of intrathecal thrombolytic therapy on subarachnoid clot and chronic vasospasm in a primate model of SAH.
Findlay JM; Weir BK; Steinke D; Tanabe T; Gordon P; Grace M
J Neurosurg; 1988 Nov; 69(5):723-35. PubMed ID: 3141595
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide Y in the primate model of subarachnoid hemorrhage.
Pluta RM; Deka-Starosta A; Zauner A; Morgan JK; Muraszko KM; Oldfield EH
J Neurosurg; 1992 Sep; 77(3):417-23. PubMed ID: 1506889
[TBL] [Abstract][Full Text] [Related]
15. Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage.
Pluta RM; Oldfield EH; Boock RJ
J Neurosurg; 1997 Nov; 87(5):746-51. PubMed ID: 9347984
[TBL] [Abstract][Full Text] [Related]
16. Controlled release of a nitric oxide donor for the prevention of delayed cerebral vasospasm following experimental subarachnoid hemorrhage in nonhuman primates.
Clatterbuck RE; Gailloud P; Tierney T; Clatterbuck VM; Murphy KJ; Tamargo RJ
J Neurosurg; 2005 Oct; 103(4):745-51. PubMed ID: 16266059
[TBL] [Abstract][Full Text] [Related]
17. Effect of clot removal at 24 hours on chronic vasospasm after SAH in the primate model.
Nosko M; Weir BK; Lunt A; Grace M; Allen P; Mielke B
J Neurosurg; 1987 Mar; 66(3):416-22. PubMed ID: 3819837
[TBL] [Abstract][Full Text] [Related]
18. Cerebral perivascular nerves in subarachnoid hemorrhage. A histochemical and immunohistochemical study.
Hara H; Nosko M; Weir B
J Neurosurg; 1986 Oct; 65(4):531-9. PubMed ID: 3760964
[TBL] [Abstract][Full Text] [Related]
19. Calcitonin-gene related peptide and cerebral vasospasm.
Schebesch KM; Herbst A; Bele S; Schödel P; Brawanski A; Stoerr EM; Lohmeier A; Kagerbauer SM; Martin J; Proescholdt M
J Clin Neurosci; 2013 Apr; 20(4):584-6. PubMed ID: 23313519
[TBL] [Abstract][Full Text] [Related]
20. Temporal changes in perivascular concentrations of oxyhemoglobin, deoxyhemoglobin, and methemoglobin after subarachnoid hemorrhage.
Pluta RM; Afshar JK; Boock RJ; Oldfield EH
J Neurosurg; 1998 Mar; 88(3):557-61. PubMed ID: 9488312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
